● Recruiting

Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients

Condition: Thrombosis · Pulmonary Embolism · Enoxaparin · Sponsor: Medical University of Vienna

PhaseN/A

Planned participants1300

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The goal of this observational study is to analyse the association between anti-factor Xa activity (antiXa) and the occurence of venous thromboembolism (VTE; either deep vein thrombosis and/or pulmonary embolism) in critically ill patients who are admitted to an intensive care unit. The main questions it aims to answer are: * What is the association between antiXa and VTE? * What is the association between antiXa and symptomatic, respectively incidental, VTE? * How is pharmacological anticoagulation with enoxaparin related to measured antiXa? * What is the association between antiXa and bleeding complications. * What is the incidence of venous thromboembolism in patients treated at an intensive care unit? * How is the occurence of VTE related to patient-centred outcomes such as mortality, quality of life, length of stay and days outside of the intensive care unit/hospital.

This description comes directly from the study's public registry record.

Talk to the study team

Christoph Dibiasi, MD · 0043 1 40400 · christoph.dibiasi@meduniwien.ac.at

Always discuss trial participation with your own doctor first.

Locations (3)

Department of Internal Medicine, Medical University of Graz	Graz, Styria, Austria	Recruiting
Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck	Innsbruck, Tyrol, Austria	Recruiting
Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna	Vienna, Austria	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06357403